News about Drug Discovery & Development

NVIDIA partners with Novo Nordisk and DCAI to advance drug discovery

NVIDIA partners with Novo Nordisk and DCAI to advance drug discovery

The companies aim to create customized AI models and agents that Novo Nordisk can use for early research and clinical development and to apply advanced simulation and physical AI technologies.

Drug Discovery & Development | 12/06/2025 | By Darshana |  277

Government Invites Fresh Applications Under PLI Scheme to Boost Bulk Drugs Production

Government Invites Fresh Applications Under PLI Scheme to Boost Bulk Drugs Production

Department of Pharmaceuticals has invited fresh applications under the performance-linked incentive (PLI) to boost bulk drug production. Focus will be on 11 key APIs, KSMs, and intermediates amid continued reliance on China. INR 6,940 crore outlay aims to strengthen domestic pharma manufacturing and reduce import dependency.

Drug Discovery & Development | 16/05/2025 | By Manvi |  694

STEERLife Redefines Potent Drug Development with Solvent-free Continuous Processing

STEERLife Redefines Potent Drug Development with Solvent-free Continuous Processing

STEERLife, the life sciences arm of STEER World, is transforming the development and manufacturing of complex and potent drug products through its proprietary solvent-free continuous processing technology.

Drug Discovery & Development | 15/05/2025 | By Manvi |  586

Cyrano Therapeutics Completes Enrollment in Phase 2 FLAVOR Trial of CYR-064 for Post-Viral Smell Loss

Cyrano Therapeutics Completes Enrollment in Phase 2 FLAVOR Trial of CYR-064 for Post-Viral Smell Loss

Cyrano Therapeutics has completed enrollment in its Phase 2 FLAVOR trial evaluating CYR-064, a novel soft-mist nasal spray for the treatment of post-viral smell loss, with results expected in late 2025.

Drug Discovery & Development | 10/04/2025 | By Manvi |  500

ProFuse Launches Drug Discovery Platform for Prevention of Muscle Loss

ProFuse Launches Drug Discovery Platform for Prevention of Muscle Loss

ProFuse's technology is based on developing methods to generate highly mature muscle tissues that accurately reflect the structure and function of natural human muscle.

Drug Discovery & Development | 05/04/2025 | By Aishwarya |  333

IRBM Expands Functional Genomics Platform to Boost Early Drug Discovery

IRBM Expands Functional Genomics Platform to Boost Early Drug Discovery

The platform integrates CRISPR-based methodologies, screening capabilities, cell engineering, and advanced molecular and cellular analysis to drive both target discovery and validation.

Drug Discovery & Development | 05/04/2025 | By Aishwarya |  419

Astellas and Japanese Foundation for Cancer Research to Accelerate Clinical Oncology Research

Astellas and Japanese Foundation for Cancer Research to Accelerate Clinical Oncology Research

Through this collaboration, Astellas is committed to strengthening translational science and clinical research in order to deliver innovative new medicines.

Drug Discovery & Development | 04/04/2025 | By Aishwarya |  454

Redwire Secures NASA Contract to Expand Pharmaceutical Drug Development in Space

Redwire Secures NASA Contract to Expand Pharmaceutical Drug Development in Space

With 28 units flown and processed to date, PIL-BOX provides pharmaceutical researchers with novel and flexible services to leverage the microgravity environment to grow small-batch crystals of protein-based pharmaceuticals and other key pharmaceutically relevant molecules.

Drug Discovery & Development | 28/03/2025 | By Aishwarya |  436

Merck Signs Exclusive License Deal for HRS-5346 with Hengrui Pharma

Merck Signs Exclusive License Deal for HRS-5346 with Hengrui Pharma

Under the agreement, Hengrui Pharma has granted Merck exclusive rights to develop, manufacture and commercialize HRS-5346 worldwide, excluding Greater China region.

Drug Discovery & Development | 26/03/2025 | By Aishwarya |  528

ENTOD Pharma Unveils Advanced Veterinary Ear Drops to Combat Ear Mites in Pets

ENTOD Pharma Unveils Advanced Veterinary Ear Drops to Combat Ear Mites in Pets

This launch marks ENTOD Pharmaceuticals' continued commitment to innovating in veterinary eye and ear care solutions under its specialised FUR by ENTOD (Veterinary) division.

Drug Discovery & Development | 26/03/2025 | By Aishwarya |  631

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members